Profile data is unavailable for this security.
About the company
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
- Revenue in INR (TTM)16.75bn
- Net income in INR145.69m
- Incorporated1962
- Employees3.12k
- LocationUnichem Laboratories LtdUnichem BhavanOff S.V.Road, Prabhat EstateJogeshwari (West)MUMBAI 400102IndiaIND
- Phone+91 2 266888333
- Fax+91 2 226784391
- Websitehttps://www.unichemlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innova Captab Ltd | -100.00bn | -100.00bn | 26.23bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.72 | -- | 6.26 | -- | -- | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 26.30bn | 1.23k | -- | 83.17 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| SeQuent Scientific Ltd | 13.75bn | -1.29bn | 30.17bn | 478.00 | -- | -- | -- | 2.19 | -5.18 | -5.18 | 55.33 | -- | -- | -- | -- | 28,769,920.00 | -- | 2.33 | -- | 3.67 | 42.78 | 42.47 | -8.97 | 2.59 | -- | -0.3894 | -- | 17.27 | 0.5728 | 10.84 | -395.83 | -- | 12.88 | -- |
| Indoco Remedies Ltd | 17.96bn | 1.02bn | 31.13bn | 6.10k | 30.90 | -- | 16.91 | 1.73 | 10.93 | 10.93 | 192.26 | -- | -- | -- | -- | 2,943,454.00 | -- | 6.07 | -- | 8.90 | 69.39 | 65.35 | 5.61 | 6.30 | -- | 5.11 | -- | 14.79 | 8.30 | 9.81 | -8.11 | 28.15 | 8.25 | 17.61 |
| Gufic BioSciences Ltd | 7.85bn | 841.95m | 32.31bn | 1.63k | 37.37 | -- | 30.63 | 4.12 | 8.62 | 8.62 | 80.38 | -- | -- | -- | -- | 4,820,074.00 | -- | 12.30 | -- | 23.08 | 51.08 | 44.91 | 10.73 | 9.84 | -- | 8.22 | -- | 1.39 | -11.36 | 17.47 | -16.84 | 37.06 | 86.82 | 14.87 |
| Supriya Lifescience Ltd | 5.54bn | 1.20bn | 33.04bn | 392.00 | 27.42 | -- | 24.42 | 5.96 | 14.97 | 14.97 | 68.93 | -- | -- | -- | -- | 14,144,410.00 | -- | 20.77 | -- | 29.06 | 61.94 | 55.83 | 21.72 | 24.33 | -- | 63.63 | -- | 2.02 | -13.04 | 16.70 | -40.81 | 59.41 | 85.55 | -- |
| Dishman Carbogen Amcis Ltd | 25.80bn | -1.54bn | 35.84bn | 1.30k | -- | -- | 24.32 | 1.39 | -9.84 | -9.84 | 164.35 | -- | -- | -- | -- | 19,919,850.00 | -- | 0.4699 | -- | 0.5665 | 76.93 | 74.36 | -5.98 | 1.82 | -- | -0.1245 | -- | 202.76 | 12.72 | 7.32 | -265.46 | -- | 21.54 | -- |
| Hikal Ltd | 18.16bn | 716.22m | 36.68bn | 2.14k | 51.25 | -- | 19.96 | 2.02 | 5.80 | 5.80 | 147.17 | -- | -- | -- | -- | 8,477,077.00 | -- | 5.86 | -- | 8.87 | 52.08 | 45.41 | 3.94 | 6.37 | -- | 2.78 | -- | 10.14 | 4.13 | 9.25 | -51.16 | 0.2973 | 23.35 | 4.42 |
| Unichem Laboratories Ltd | 16.75bn | 145.69m | 42.27bn | 3.12k | 290.56 | -- | 32.43 | 2.52 | 2.07 | 2.07 | 234.69 | -- | -- | -- | -- | 5,364,373.00 | -- | -1.38 | -- | -1.66 | 59.94 | 56.15 | 0.8696 | -3.60 | -- | -0.9613 | -- | -- | 5.76 | 10.51 | -711.67 | -- | -22.60 | -- |
| Advanced Enzyme Technologies Ltd | 6.05bn | 1.37bn | 44.16bn | 338.00 | 32.16 | -- | 25.44 | 7.30 | 12.28 | 12.28 | 54.16 | -- | -- | -- | -- | 17,892,400.00 | -- | 11.87 | -- | 13.19 | 76.42 | 72.20 | 23.02 | 25.79 | -- | 59.04 | -- | 7.49 | 2.13 | 6.44 | -11.66 | 3.24 | 28.32 | 14.87 |
| Aarti Drugs Ltd | 26.51bn | 1.80bn | 46.21bn | 1.50k | 25.75 | -- | 20.02 | 1.74 | 19.52 | 19.52 | 287.30 | -- | -- | -- | -- | 17,673,360.00 | -- | 9.91 | -- | 16.40 | 32.25 | 22.33 | 6.81 | 8.23 | -- | 8.29 | -- | 5.53 | 9.14 | 16.56 | -18.89 | 15.11 | 17.20 | 31.95 |
| Aarti Pharmalabs Ltd | 18.32bn | 1.95bn | 46.39bn | 1.40k | 23.85 | -- | 17.53 | 2.53 | 21.47 | 21.47 | 202.17 | -- | -- | -- | -- | 13,085,090.00 | -- | -- | -- | -- | 42.00 | -- | 10.62 | -- | -- | 16.14 | -- | -- | 62.11 | -- | 58.27 | -- | -- | -- |
| Shilpa Medicare Ltd | 11.23bn | -6.71m | 52.52bn | 1.03k | -- | -- | 49.39 | 4.68 | -0.0714 | -0.0714 | 131.44 | -- | -- | -- | -- | 10,873,050.00 | -- | 3.89 | -- | 4.92 | 64.42 | 60.22 | -0.0538 | 9.29 | -- | 1.16 | -- | 10.65 | -8.33 | 5.82 | -153.54 | -- | 14.58 | -- |
| Orchid Pharma Ltd | 8.12bn | 1.25bn | 52.96bn | 838.00 | 36.64 | -- | 33.32 | 6.52 | 28.50 | 26.84 | 175.33 | -- | -- | -- | -- | 9,691,729.00 | -- | -1.07 | -- | -1.96 | 41.49 | 45.87 | 15.63 | -3.52 | -- | 4.34 | -- | -- | 19.00 | -0.6456 | 187.87 | -- | 68.72 | -- |
Data as of May 03 2024. Currency figures normalised to Unichem Laboratories Ltd's reporting currency: Indian Rupee INR
10.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Mar 2024 | 5.61m | 7.97% |
| DSP Asset Managers Pvt. Ltd.as of 31 Mar 2024 | 735.59k | 1.05% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 31 Mar 2024 | 537.25k | 0.76% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 517.62k | 0.74% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 34.27k | 0.05% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 15.25k | 0.02% |
| DFA Australia Ltd.as of 31 Mar 2024 | 6.32k | 0.01% |
| American Century Investment Management, Inc.as of 04 Apr 2024 | 1.19k | 0.00% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Mar 2024 | 448.00 | 0.00% |
| Groww Asset Management Ltd.as of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 02 May 2024Source: FactSet Research Systems Inc.
